Richter, S., Seah, J.-A., Pond, G. R., Gan, H. K., Mackenzie, M. J., Hotte, S. J., … Sridhar, S. S. (2014). Evaluation of second line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first line cediranib. Canadian Urological Association Journal, 8(11-12), 398–402. https://doi.org/10.5489/cuaj.2426